Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

Treatment with dupilumab is associated with weight gain in about two thirds of adults with atopic dermatitis over 3-6 months, ...

How Was Adbry Studied for Treating Atopic Dermatitis? Three clinical studies called ECZTRA 1, 2, and 3 were done to test Adbry’s effectiveness for treating atopic dermatitis (eczema) in adults.

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar.

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the most promising stocks according to Wall Street analysts. On June 26, ...

When someone has atopic dermatitis, the barrier is “leaky,” said Dr. Joy Wan, an assistant professor of dermatology at Johns Hopkins University.

130.1-400 for severe atopic dermatitis "The IGA is 0 to 4, and the BSA is 0 to 100%, so the levels are very simple," said Paller, one of the co-authors of the validation study.

Atopic dermatitis (eczema) is a chronic skin condition that causes dry, itchy red patches to appear on different parts of the body, including the elbows, knees and neck. When atopic dermatitis is ...

Atopic dermatitis causes flaky, itchy, dry, and inflamed skin. It can look different on darker skin, making it harder to spot or treat.

Discover a study that links air pollution and climate extremes to increased severity and prevalence of atopic dermatitis.

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...